These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25172213)

  • 41. [From gene to disease: copper-transporting P ATPases alteration].
    Garcia Hejl C; Vrignaud C; Garcia C; Ceppa F
    Pathol Biol (Paris); 2009 May; 57(3):272-9. PubMed ID: 19046832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.
    de Bie P; Muller P; Wijmenga C; Klomp LW
    J Med Genet; 2007 Nov; 44(11):673-88. PubMed ID: 17717039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome.
    Møller LB; Tümer Z; Lund C; Petersen C; Cole T; Hanusch R; Seidel J; Jensen LR; Horn N
    Am J Hum Genet; 2000 Apr; 66(4):1211-20. PubMed ID: 10739752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular correlates of epilepsy in early diagnosed and treated Menkes disease.
    Kaler SG; Liew CJ; Donsante A; Hicks JD; Sato S; Greenfield JC
    J Inherit Metab Dis; 2010 Oct; 33(5):583-9. PubMed ID: 20652413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Menkes disease.
    Bertini I; Rosato A
    Cell Mol Life Sci; 2008 Jan; 65(1):89-91. PubMed ID: 17989919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.
    León-García G; Santana A; Villegas-Sepúlveda N; Pérez-González C; Henrríquez-Esquíroz JM; de León-García C; Wong C; Baeza I
    BMC Pediatr; 2012 Sep; 12():150. PubMed ID: 22992316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Menkes copper-translocating P-type ATPase (ATP7A): biochemical and cell biology properties, and role in Menkes disease.
    Voskoboinik I; Camakaris J
    J Bioenerg Biomembr; 2002 Oct; 34(5):363-71. PubMed ID: 12539963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase.
    Kim BE; Smith K; Petris MJ
    J Med Genet; 2003 Apr; 40(4):290-5. PubMed ID: 12676902
    [No Abstract]   [Full Text] [Related]  

  • 49. A numerical investigation into possible mechanisms by that the A629P mutant of ATP7A causes Menkes Disease.
    Kouza M; Gowtham S; Seel M; Hansmann UH
    Phys Chem Chem Phys; 2010 Oct; 12(37):11390-7. PubMed ID: 20714486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Copper Toxicity Associated With an ATP7A-Related Complex Phenotype.
    Natera-de Benito D; Sola A; Sousa PR; Boronat S; Expósito-Escudero J; Carrera-García L; Ortez C; Jou C; Muchart J; Rebollo M; Armstrong J; Colomer J; Garcia-Cazorla À; Hoenicka J; Palau F; Nascimento A
    Pediatr Neurol; 2021 Jun; 119():40-44. PubMed ID: 33894639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Menkes copper transporter is required for the activation of tyrosinase.
    Petris MJ; Strausak D; Mercer JF
    Hum Mol Genet; 2000 Nov; 9(19):2845-51. PubMed ID: 11092760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Menkes syndrome and animal models.
    Mercer JF
    Am J Clin Nutr; 1998 May; 67(5 Suppl):1022S-1028S. PubMed ID: 9587146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterizing the molecular phenotype of an Atp7a(T985I) conditional knock in mouse model for X-linked distal hereditary motor neuropathy (dHMNX).
    Perez-Siles G; Grant A; Ellis M; Ly C; Kidambi A; Khalil M; Llanos RM; Fontaine SL; Strickland AV; Züchner S; Bermeo S; Neist E; Brennan-Speranza TC; Takata RI; Speck-Martins CE; Mercer JF; Nicholson GA; Kennerson ML
    Metallomics; 2016 Sep; 8(9):981-92. PubMed ID: 27293072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the mutation spectra of Menkes disease and Wilson disease.
    Hsi G; Cox DW
    Hum Genet; 2004 Jan; 114(2):165-72. PubMed ID: 14579150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel ATP7A gross deletion mutation in a Korean patient with Menkes disease.
    Park HD; Moon HK; Lee J; Lee M; Lee SY; Kim JW; Ki CS
    Ann Clin Lab Sci; 2009; 39(2):188-91. PubMed ID: 19429807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Menkes disease ATPase (ATP7A) is internalized via a Rac1-regulated, clathrin- and caveolae-independent pathway.
    Cobbold C; Coventry J; Ponnambalam S; Monaco AP
    Hum Mol Genet; 2003 Jul; 12(13):1523-33. PubMed ID: 12812980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic and molecular bases of Menkes disease and occipital horn syndrome.
    Kaler SG
    Pediatr Dev Pathol; 1998; 1(1):85-98. PubMed ID: 10463276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation spectrum of ATP7A, the gene defective in Menkes disease.
    Tümer Z; Møller LB; Horn N
    Adv Exp Med Biol; 1999; 448():83-95. PubMed ID: 10079817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases].
    Lenartowicz M; Krzeptowski W
    Postepy Biochem; 2010; 56(3):317-27. PubMed ID: 21117320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intragenic deletions at Atp7a in mouse models for Menkes disease.
    Cunliffe P; Reed V; Boyd Y
    Genomics; 2001 Jun; 74(2):155-62. PubMed ID: 11386751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.